Vext Science, Inc.
VEXTF
$0.19
$0.001.60%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 51.97M | 51.37M | 47.83M | 44.15M | 39.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.97M | 51.37M | 47.83M | 44.15M | 39.17M |
| Cost of Revenue | 34.27M | 36.91M | 34.58M | 30.89M | 29.23M |
| Gross Profit | 17.70M | 14.45M | 13.26M | 13.26M | 9.94M |
| SG&A Expenses | 16.77M | 15.68M | 14.67M | 14.64M | 14.76M |
| Depreciation & Amortization | 5.73M | 5.60M | 5.45M | 5.31M | 5.15M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.77M | 58.20M | 54.70M | 50.84M | 49.14M |
| Operating Income | -4.80M | -6.83M | -6.86M | -6.69M | -9.97M |
| Income Before Tax | -12.30M | -15.22M | -13.36M | -13.22M | -18.00M |
| Income Tax Expenses | 3.25M | 2.78M | 3.30M | 3.30M | 1.43M |
| Earnings from Continuing Operations | -15.56 | -18.00 | -16.66 | -16.52 | -19.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.56M | -18.00M | -16.66M | -16.52M | -19.44M |
| EBIT | -4.80M | -6.83M | -6.86M | -6.69M | -9.97M |
| EBITDA | 10.32M | 8.31M | 8.13M | 8.16M | 4.58M |
| EPS Basic | -0.06 | -0.07 | -0.07 | -0.07 | -0.08 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.03 | -0.03 | -0.05 |
| EPS Diluted | -0.07 | -0.08 | -0.07 | -0.07 | -0.08 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.03 | -0.03 | -0.05 |
| Average Basic Shares Outstanding | 990.57M | 990.37M | 990.13M | 988.07M | 985.94M |
| Average Diluted Shares Outstanding | 990.57M | 990.37M | 990.13M | 991.17M | 989.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |